Veterinary Medicines

Mastitar Retard Vet. intramammær salve 500.000 IE+300 mg

Authorised
  • Neomycin
  • Benzylpenicillin procaine
Download as PDF

Product identification

Medicine name:
Mastitar Retard Vet. 500.000 IE +300 mg intramammær salve
Mastitar Retard Vet. intramammær salve 500.000 IE+300 mg
Active substance:
  • Neomycin
  • Benzylpenicillin procaine
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Neomycin
    300.00
    milligram(s)
    /
    1.00
    Syringe
  • Benzylpenicillin procaine
    500.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        10
        day
      • Meat and offal
        10
        day
      • Milk
        4
        day
      • Milk
        4
        day
      • Milk
        30
        day
      • Milk
        30
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • VIRBAC
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 09168
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, INTRAMAMMÆR SALVE)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."